In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also secreting immunoregulatory cytokines and identifying and eliminating autoreactive T cells that contribute to neuroinflammation.
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
Home »
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
Ähnliche Beiträge
Trump Offloads Ebola-Infected American Citizen to Germany
Berlin/Washington (LabNews Media LLC) – A U.S. medical missionary infected with the Bundibugyo strain of Ebola virus disease (EVD) has been evacuated to Berlin’s Charité…
Kanada investiert 6,8 Millionen Dollar in KI-Projekte in Alberta
Edmonton (LabNews Media LLC) – Die kanadische Bundesregierung fördert fünf Projekte in Alberta mit insgesamt 6,8 Millionen Dollar über die Regional Artificial Intelligence Initiative (RAII).…
Ebola in Deutschland: Kaum Sonderisoliertstationen (SIS)
Berlin (LabNews Media LLC) – Die Weltgesundheitsorganisation (WHO) hat den Ebola-Ausbruch mit der Bundibugyo-Variante in der Demokratischen Republik Kongo und Uganda als internationale gesundheitliche Notlage…
